Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this newsletter: Idris Aderoju, PharmD Candidate, Florida A&M College of Pharmacy Dalia Elabed, PharmD Candidate 2022, University of South Florida Taneja College of Pharmacy Erica Hicks, PharmD Candidate 2022, South College School of Pharmacy Kornelia Ilias, Creighton University | School of Pharmacy and Health Professions Doctor of Pharmacy Candidate Class of 2022 Kandarp Mehta, MS, PharmD Candidate, University of Colorado Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences Ding Nguyen, PharmD Candidate, University of South Florida Taneja College of Pharmacy | 
Dalia Elabed, PharmD Candidate, University of South Florida, and Kandarp Mehta, MS, PharmD Candidate, University of Colorado, spent a lot of time the past two weeks focused on the SGLT-2, canagliflozin. They reviewed multiple studies, including DAPA-HF, EMPEROR-REDUCED, SOLOIST-WHF, CANVAS and CANVAS-R, to put together two very concise articles on the